Kynam Capital Management, LP

Kynam Capital Management, LP reported 34 holdings worth US$1.81B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Kynam Capital Management, LP reported 34 holdings worth US$1.81B as of Sep 30, 2026. Largest: Legend Biotech Corp., Celldex Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
34
Value as reported
US$1.81B

The filing in full

CompanySharesValue as reported% of portfolio
Legend Biotech Corp.9.15MUS$182M10.1%
Celldex Therapeutics, Inc.5.07MUS$164M9.1%
Syndax Pharmaceuticals, Inc.8.15MUS$153M8.5%
Vaxcyte, Inc.2.61MUS$148M8.2%
Viridian Therapeutics, Inc.6.15MUS$127M7.0%
Cogent Biosciences, Inc.3.79MUS$121M6.7%
Travere Therapeutics, Inc.2MUS$118M6.5%
Vera Therapeutics, Inc.3MUS$96.9M5.4%
Beam Therapeutics Inc.3.93MUS$96.2M5.3%
CytomX Therapeutics, Inc.21.1MUS$57.5M3.2%
MBX Biosciences, Inc.935KUS$54.8M3.0%
Summit Therapeutics Inc.3MUS$50.7M2.8%
Relay Therapeutics, Inc.2.75MUS$49.7M2.7%
Cullinan Therapeutics, Inc.3.11MUS$47.8M2.6%
Immunocore Holdings plc1.38MUS$41.6M2.3%
Nurix Therapeutics, Inc.1.19MUS$28.3M1.6%
Burning Rock Biotech Ltd.1.24MUS$21.8M1.2%
BioCryst Pharmaceuticals, Inc.2.52MUS$21M1.2%
Surrozen, Inc.486KUS$15.6M0.87%
Sutro Biopharma, Inc.873KUS$14.1M0.78%
Xenon Pharmaceuticals Inc.280KUS$10.4M0.58%
Evommune, Inc.1.2MUS$9.91M0.55%
Prelude Therapeutics Incorporated2.31MUS$9.04M0.50%
Geron Corporation6.84MUS$8.41M0.47%
Parabilis Medicines, Inc.250KUS$8.07M0.45%
Alector, Inc.4.31MUS$7.97M0.44%
Amarin Corporation plc533KUS$6.93M0.38%
Harrow, Inc.125KUS$3.84M0.21%
Caribou Biosciences, Inc.2.5MUS$3.18M0.18%
Traws Pharma, Inc.84,400US$50,117<0.01%
Candel Therapeutics, Inc.0US$00.00%
Insmed Incorporated0US$00.00%

Source

Download original · View original at SEC

Related